Pharmacological properties of the rhesus macaque monkey P2X7 receptor

British Journal of Pharmacology

Volumn 164, Issue 2 B, 2011, Pages 743-754

  Bradley, Helen J ^a   Browne, Liam E ^b   Yang, Wei ^a,c   Jiang, Lin Hua ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

A 438079; ATP; AZ11645373; BzATP; KN 62; rhesus macaque monkey P2X7 receptor

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2'(3') O (4 BENZOYLBENZOYL) ADENOSINE 5' TRIPHOSPHATE; A 438079; ADENOSINE TRIPHOSPHATE; AZ 11645737; PURINERGIC P2X7 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RHESUS MONKEY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADENOSINE TRIPHOSPHATE; AMINO ACID SEQUENCE; ANIMALS; BENZOXAZOLES; HEK293 CELLS; HUMANS; MACACA MULATTA; MEMBRANE POTENTIALS; MOLECULAR SEQUENCE DATA; PATCH-CLAMP TECHNIQUES; PURINERGIC P2X RECEPTOR AGONISTS; PURINERGIC P2X RECEPTOR ANTAGONISTS; PYRIDINES; QUINOLINIUM COMPOUNDS; RECEPTORS, PURINERGIC P2X7; SINGLE-CELL ANALYSIS; TETRAZOLES; THIAZOLES;

EID: 80052216594     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01399.x     Document Type: Article

References (58)

1. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 (Suppl. 1): S1-S254.
2. Bradley HJ, Liu X, Collins V, Owide J, Goli GR, Smith M, et al,. (2010). Identification of an intracellular microdomain of the P2X7 receptor that is crucial in basolateral membrane targeting in epithelial cells. FEBS Lett 584: 4740-4744.
3. Bradley HJ, Baldwin JM, Goli GR, Johnson B, Zou J, Sivaprasadarao A, et al,. (2011). Residues 155 and 348 contribute to determination of P2X7 receptor function via distinct mechanisms revealed by single nucleotide polymorphisms. J Biol Chem 286: 8176-8187.
4. Browne LE, Jiang LH, North RA, (2010). New structure enlivens interest in P2X receptors. Trends Pharmacol Sci 31: 229-237.
5. Chen J, Kym PR, (2009). TRPA1: the species difference. J Gen Physiol 133: 623-625.
6. Chessell IP, Simon J, Hibell AD, Michel AD, Barnard EA, Humphrey PP, (1998). Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett 439: 26-30. (Pubitemid 28537856)
7. Chessell IP, Hatcher JP, Bountra C, Michel AD, Hughes JP, Green P, et al,. (2005). Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114: 386-396. (Pubitemid 40385877)
8. Choi HB, Ryu JK, Kim SU, McLarnon JG, (2007). Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J Neurosci 27: 4957-4968. (Pubitemid 46699068)
9. Di Virgilio F, (2007). Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 28: 465-472.
10. Díaz-Hernández M, Díez-Zaera M, Sánchez- Nogueiro J, Gõmez-Villafuertes R, Canals JM, Alberch J, et al,. (2009). Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration. FASEB J 23: 1893-1906.
11. Donnelly-Roberts DL, Jarvis MF, (2007). Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 151: 571-579. (Pubitemid 47016292)
12. Donnelly-Roberts DL, Namovic MT, Han P, Jarvis MF, (2009). Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157: 1203-1214.
13. Duan S, Neary JT, (2006). P2X(7) receptors: properties and relevance to CNS function. Glia 54: 738-746. (Pubitemid 44629636)
14. Evans RJ, (2010). Structural interpretation of P2X receptor mutagenesis studies on drug action. Br J Pharmacol 161: 961-971.
15. Fonfria E, Clay WC, Levy DS, Goodwin JA, Roman S, Smith GD, et al,. (2008). Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue. Br J Pharmacol 153: 544-556. (Pubitemid 351199022)
16. Gorodeski GI, (2010). P2X7-mediated chemoprevention of epithelial cancers. Expert Opin Ther Targets 13: 1313-1332.
17. Guile SD, Alcaraz L, Birkinshaw TN, Bowers KC, Ebden MR, Furber M, et al,. (2009). Antagonists of the P2X(7) receptor. From lead identification to drug development. J Med Chem 52: 3123-3141.
18. Han X, Qian X, Bernstein JG, Zhou HH, Franzesi GT, Stern P, et al,. (2009). Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 6: 191-198.
19. Hibell AD, Kidd EJ, Chessell IP, Humphrey PP, Michel AD, (2000). Apparent species differences in the kinetic properties of P2X(7) receptors. Br J Pharmacol 130: 167-173. (Pubitemid 30248441)
20. Humphreys BD, Virginio C, Surprenant A, Rice J, Dubyak GR, (1998). Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol 54: 22-32. (Pubitemid 28337583)
21. Jarvis MF, (2010). The neural-glial purinergic receptor ensemble in chronic pain states. Trends Neurosci 33: 48-57.
22. Jiang LH, Mackenzie AB, North RA, Surprenant A, (2000). Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol Pharmacol 58: 82-88. (Pubitemid 30452530)
23. Jiang LH, Rassendren F, Mackenzie A, Zhang YH, Surprenant A, North RA, (2005). N-methyl-D-glucamine and propidium dyes utilize different permeation pathways at rat P2X(7) receptors. Am J Physiol Cell Physiol 289: C1295-C1302. (Pubitemid 41456846)
24. Kawate T, Michel JC, Birdsong WT, Gouaux E, (2009). Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460: 592-598.
25. Kucenas S, Li Z, Cox JA, Egan TM, Voigt MM, (2003). Molecular characterization of the zebrafish P2X receptor subunit gene family. Neuroscience 121: 935-945. (Pubitemid 37324593)
26. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, et al,. (2002). Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168: 6436-6445. (Pubitemid 34620068)
27. Liu X, Surprenant A, Mao HJ, Roger S, Xia R, Bradley H, et al,. (2008). Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Mol Pharmacol 73: 252-259. (Pubitemid 350294216)
28. McGaraughty S, Chu KL, Namovic MT, Donnelly-Roberts DL, Harris RR, Zhang XF, et al,. (2007). P2X7-related modulation of pathological nociception in rats. Neuroscience 146: 1817-1828. (Pubitemid 46783230)
29. Matute C, Torre I, Pérez-Cerdá F, Pérez- Samartín A, Alberdi E, Etxebarria E, et al,. (2007). P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J Neurosci 27: 9525-9533. (Pubitemid 47358223)
30. Mei ZZ, Xia R, Beech DJ, Jiang LH, (2006). Intracellular coiled-coil domain engaged in subunit interaction and assembly of melastatin-related transient receptor potential channel 2. J Biol Chem 281: 38748-38756. (Pubitemid 46042002)
31. Michel AD, Ng SW, Roman S, Clay WC, Dean DK, Walter DS, (2009). Mechanism of action of species-selective P2X(7) receptor antagonists. Br J Pharmacol 156: 1312-1325.
32. Monif M, Reid CA, Powell KL, Smart ML, Williams DA, (2009). The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci 29: 3781-3791.
33. Neary JT, Zimmermann H, (2009). Trophic functions of nucleotides in the central nervous system. Trends Neurosci 32: 189-198.
34. North RA, (2002). Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
35. North RA, Surprenant A, (2000). Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 40: 563-580. (Pubitemid 30340693)
36. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R, (2003). P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278: 13309-13317. (Pubitemid 36800102)
37. Paukert M, Hidayat S, Gründer S, (2002). The P2X(7) receptor from Xenopus laevis: formation of a large pore in Xenopus oocytes. FEBS Lett 513: 253-258. (Pubitemid 34251274)
38. Pelegrin P, Surprenant A, (2006). Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J 25: 5071-5082. (Pubitemid 44658525)
39. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al,. (2004). UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.
40. Ralevic V, Burnstock G, (1998). Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492. (Pubitemid 28477681)
41. Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A, (1997). The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem 272: 5482-55486.
42. Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, et al,. (2010a). Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res 44: 347-355.
43. Roger S, Gillet L, Baroja-Mazo A, Surprenant A, Pelegrin P, (2010b). C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem 285: 17514-17524.
44. Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez-Cara C, Preti D, Borea PA, et al,. (2008). The P2X7 receptor as a therapeutic target. Expert Opin Ther Targets 12: 647-661.
45. Roman S, Cusdin FS, Fonfria E, Goodwin JA, Reeves J, Lappin SC, et al,. (2009). Cloning and pharmacological characterization of the dog P2X7 receptor. Br J Pharmacol 158: 1513-1526.
46. Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, et al,. (2009). Activation of microglia by amyloid {beta} requires P2X7 receptor expression. J Immunol 182: 4378-4385.
47. Sasaki E, Suemizu H, Shimada A, Hanazawa K, Oiwa R, Kamioka M, et al,. (2009). Generation of transgenic non-human primates with germline transmission. Nature 459: 523-527.
48. Schatten G, Mitalipov S, (2009). Developmental biology: transgenic primate offspring. Nature 459: 515-516.
49. Skaper SD, Debetto P, Giusti P, (2010). The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB J 24: 337-345.
50. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, et al,. (2001). Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276: 125-132. (Pubitemid 32050297)
51. Stokes L, Jiang LH, Alcaraz L, Bent J, Bowers K, Fagura M, et al,. (2006). Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br J Pharmacol 149: 880-887. (Pubitemid 44851712)
52. Surprenant A, North RA, (2009). Signaling at purinergic P2X receptors. Annu Rev Physiol 71: 333-359.
53. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G, (1996). The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738.
54. Wilkinson WJ, Jiang LH, Surprenant A, North RA, (2006). Role of ectodomain lysines in the subunits of the heteromeric P2X2/3 receptor. Mol Pharmacol 70: 1159-1163. (Pubitemid 44435966)
55. Xia R, Mei ZZ, Mao HJ, Yang W, Dong L, Bradley H, et al,. (2008). Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel 2. J Biol Chem 283: 27426-27432.
56. Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, et al,. (2008). Towards a transgenic model of Huntington's disease in a non-human primate. Nature 453: 921-924. (Pubitemid 351832563)
57. Young MT, Pelegrin P, Surprenant A, (2007). Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol 71: 92-100. (Pubitemid 46020980)
58. Zhou D, Chen ML, Zhang YQ, Zhao ZQ, (2010). Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci 30: 8042-8047.